Prelude initiates phase I study of PRT-811 in advanced solid tumors, gliomas and myelofibrosis Nov. 13, 2019
MAb targeting TREM1+ myeloid cells boosts antitumor immunity and checkpoint inhibitor sensitivity Nov. 13, 2019
Role of p300 in BRD4-NUT-driven NUT carcinomas and novel dual BET/p300 bromodomain inhibitors Nov. 13, 2019
Otsuka and Avanir decide to continue development of AVP-786 for agitation in Alzheimer's dementia Nov. 12, 2019
European Commission grants conditional marketing authorization to Ebola Zaire vaccine Ervebo Nov. 12, 2019
Phase III portion of CARDINAL study of bardoxolone in Alport syndrome meets primary endpoint Nov. 12, 2019
New anti-CD147 antibodies induce SMAD and JNK signaling and tumor shrinkage in xenograft models Nov. 12, 2019
RSS